INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. - NUAI
GlobeNewswire
Today at 8:08pm UTC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hercules Capital, Inc. of Class Action Lawsuit and...
GlobeNewswire
Today at 8:07pm UTC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChowChow Cloud International Holdings Ltd. - CHOW
GlobeNewswire
Today at 8:07pm UTC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coty Inc. Of Class Action Lawsuit and Upcoming...
GlobeNewswire
Today at 8:06pm UTC
/DISREGARD RELEASE: American Warrior Association/
PR Newswire
Today at 8:06pm UTC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit...
GlobeNewswire
Today at 8:05pm UTC
NAVAN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Navan, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before...
GlobeNewswire
Today at 8:05pm UTC
American Public Education, Inc. Schedules First Quarter 2026 Earnings Call and Announces Upcoming Conference Participation
PR Newswire
Today at 8:05pm UTC
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire
Today at 8:05pm UTC
Chubb Reports First Quarter Per Share Net Income and Core Operating Income of $5.88 and $6.82, Respectively, Up 78.8% and 85.2%;...
PR Newswire
Today at 8:05pm UTC
TELA Bio to Announce First Quarter 2026 Financial Results
GlobeNewswire
Today at 8:05pm UTC
Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal...
PR Newswire
Today at 8:05pm UTC
AvePoint to Announce First Quarter 2026 Financial Results on May 7
GlobeNewswire
Today at 8:05pm UTC
Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
PR Newswire
Today at 8:05pm UTC
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader...
GlobeNewswire
Today at 8:05pm UTC
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
PR Newswire
Today at 8:05pm UTC
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Today at 8:05pm UTC
Resideo To Release First Quarter 2026 Financial Results on May 12, 2026
PR Newswire
Today at 8:05pm UTC
Beeline to Host Stakeholder Update Call on Q1 2026 Financial Results
GlobeNewswire
Today at 8:05pm UTC
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
GlobeNewswire
Today at 8:05pm UTC